Merk reported $220.98B in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbott ABT:US $ 190.24B 17B
Abbvie ABBV:US $ 270.65B 15.68B
ALKERMES ALKS:US 4.89B 0.63B
Amgen AMGN:US $ 129.97B 0.89B
AstraZeneca AZN:LN 16734.4B 1035.33B
Astrazeneca AZN:US 203.74B 2.44B
Biogen BIIB:US $ 29.87B 1.08B
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Catalent CTLT:US $ 19.23B 0.64B
Coherus Biosciences CHRS:US $ 0.56B 0.44B
Drreddys Laboratories RDY:US 9.24B 0.16B
Eli Lilly And LLY:US $ 308.07B 35.35B
Endo International Ordinary Shares ENDP:US 0.11B 0.43B
Gilead Sciences GILD:US $ 77.53B 2.87B
GlaxoSmithKline GSK:LN 8976.58B 602.38B
Glaxosmithkline GSK:US 109.29B 0.69B
Horizon Pharma HZNP:US 18.34B 5.81B
Intercept Pharmaceuticals ICPT:US $ 0.41B 0.07B
JAZZ PHA JAZZ:US 9.74B 0.13B
Johnson & Johnson JNJ:US $ 467.1B 1.05B
Medtronic MDT:US 119.25B 29.59B
Merk MRK:US $ 230.55B 23.1B
Novartis NOVN:VX 194.34B 3.46B
Novartis NVS:US 203.52B 10.87B
Pacira Pharmaceuticals PCRX:US $ 2.65B 0.77B
Perrigo Ordinary Shares PRGO:US 5.46B 0.29B
Pfizer PFE:US $ 294.18B 1.79B
Phibro Animal Health PAHC:US $ 0.78B 0.03B
Prestige Brands PBH:US $ 2.94B 0.28B
Regeneron Pharmaceuticals REGN:US $ 64.93B 10.87B
Revance Therapeutics RVNC:US $ 1.01B 0.39B
Roche Holding ROG:VX 300.5B 1.25B
Sanofi SAN:FP 121.89B 4.99B
Sanofi SNY:US 127.77B 1.58B
Teva Pharmaceutical Industries TEVA:US 8.48B 1.81B
United Therapeutics UTHR:US $ 10.67B 2.55B
Zoetis ZTS:US $ 80.9B 7.98B